- Home
- LXRX vs VYX Comparison
LXRX vs VYX Comparison
Compare LXRX & VYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LXRX | VYX |
|---|---|---|
| Founded | 1995 | 1881 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 990.6M | 1.1B |
| IPO Year | 2000 | 1996 |
Fundamental Metrics
Financial Performance| Metric | LXRX | VYX |
|---|---|---|
| Price | $2.42 | $7.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $4.15 | ★ $13.67 |
| AVG Volume (30 Days) | ★ 2.8M | 2.1M |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $49,803,000.00 | ★ $7,156,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 60.24 | 15.29 |
| 52 Week Low | $1.03 | $6.02 |
| 52 Week High | $2.68 | $13.82 |
Technical Indicators
Market Signals| Indicator | LXRX | VYX |
|---|---|---|
| Relative Strength Index (RSI) | 54.87 | 43.98 |
| Support Level | $2.01 | $7.32 |
| Resistance Level | $2.50 | $8.41 |
| Average True Range (ATR) | 0.15 | 0.49 |
| MACD | -0.01 | -0.12 |
| Stochastic Oscillator | 81.14 | 5.22 |
Price Performance
Historical ComparisonAbout LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About VYX NCR Voyix Corporation
NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in two reportable segments: Retail, and Restaurants. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The company derives maximum revenue from Retail segment. Geographically, the company operates in United States, Americas (excluding United States), Europe, Middle East and Africa, and Asia Pacific. It derives maximum revenue from United States.